Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
September 5, 2025 - … Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with … to report side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. … is available on the Company's website at www.theratech.com , on SEDAR+ at www.sedarplus.ca and on EDGAR at …
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
September 2, 2025 - … Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak … of 10:00 a.m. (Eastern time) on September 10, 2025. Visit www.theratech.com for more information. Questions or require voting … Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak …
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
August 18, 2025 - … purchase price of US$3.01, with a contingent value right for potential additional aggregate payments of up to US$1.19 … of 10:00 a.m. (Eastern time) on September 10, 2025. Visit www.theratech.com for more information. Questions or … Purchaser, Future Pak and the Company is the result of the sale process previously announced by the Company that was led …
Theratechnologies Reports Financial Results for the Second Quarter 2025
July 9, 2025 - … Theratechnologies Reports Financial Results for the Second Quarter 2025 Theratechnologies Reports … on EDGAR at www.sec.gov and at www.theratech.com . Unless specified otherwise, all capitalized terms have … fees ($1,359,000) incurred with respect to the sale process announced by the Company on April 15, 2025. The …
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
July 2, 2025 - … Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 … Transaction with Future Pak represents culmination of sale process whereby Theratechnologies solicited interest … is available on the Company's website at www.theratech.com , on SEDAR+ at www.sedarplus.ca and on EDGAR at …
Theratechnologies présente à la conférence ACTHIV 2025 de nouvelles données soulignant l’importance de prendre en charge l’excès de graisse viscérale abdominale chez les personnes vivant avec le VIH
May 2, 2025 - … d’affiches à la 19 e édition de l’ American Conference for the Treatment of HIV (ACTHIV 2025), qui aura lieu du 1 er … deux affiches se trouveront sur les sites www.theratech.com/fr et www.acthiv.org après la conférence. À propos de … disponibles sur le site Web de la Société au www.theratech.com , sur SEDAR+ au www.sedarplus.ca et sur EDGAR au …
Theratechnologies Provides Update on Sale Process
April 15, 2025 - … Theratechnologies Provides Update on Sale Process Theratechnologies Provides Update on Sale … is available on the Company's website at www.theratech.com , on SEDAR+ at www.sedarplus.ca and on EDGAR at … proposal received by the Company from Future Pak for the acquisition of the Company; the review and evaluation …
Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company
April 11, 2025 - … Exclusive Discussions with Another Potential Acquiror for the Sale of the Company Theratechnologies Responds to Future … is available on the Company's website at www.theratech.com , on SEDAR+ at www.sedarplus.ca and on EDGAR at … Exclusive Discussions with Another Potential Acquiror for the Sale of the Company …
Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
April 9, 2025 - … Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements … on EDGAR at www.sec.gov and at www.theratech.com . Unless specified otherwise, all capitalized terms have … included a $10,000,000 upfront payment to Ionis, while the sale of bonds and money market funds generated proceeds of …
Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA
April 8, 2025 - … Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA Theratechnologies Receives FDA Approval … to report side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. Refer to www.egriftasv.com for the full prescribing information, patient …